These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16195428)

  • 1. U.S. biomedical policy. NCI head to fill in at FDA after Crawford resignation.
    Couzin J; Kaiser J
    Science; 2005 Sep; 309(5744):2142-3. PubMed ID: 16195428
    [No Abstract]   [Full Text] [Related]  

  • 2. U.S. biomedical policy. Acting FDA head drops NCI post.
    Kaiser J
    Science; 2005 Oct; 310(5745):29. PubMed ID: 16210502
    [No Abstract]   [Full Text] [Related]  

  • 3. U.S. science policy. Cancer institute director tapped for FDA.
    Kaiser J; Couzin J
    Science; 2006 Mar; 311(5768):1692. PubMed ID: 16556808
    [No Abstract]   [Full Text] [Related]  

  • 4. 2006 people to watch. Double trouble?
    Science; 2006 Jan; 311(5757):35. PubMed ID: 16400129
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA not NIH can speed new drugs.
    Miller HI
    Nature; 2011 Apr; 472(7342):169. PubMed ID: 21490657
    [No Abstract]   [Full Text] [Related]  

  • 6. Experts trying to repair split in health bureaucracy.
    Zoler ML
    Med World News; 1989 Feb; 30(3):77. PubMed ID: 10294488
    [No Abstract]   [Full Text] [Related]  

  • 7. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R
    J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA gets Kessler; NIH gets left out.
    Culliton BJ
    Science; 1990 Nov; 250(4982):749. PubMed ID: 2237422
    [No Abstract]   [Full Text] [Related]  

  • 9. NCI, FDA to collaborate on speeding up drug discovery.
    Arnold K
    J Natl Cancer Inst; 2003 Aug; 95(16):1192. PubMed ID: 12928341
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA upgrade proposed.
    Gershon D
    Nature; 1991 May; 351(6324):258. PubMed ID: 1851962
    [No Abstract]   [Full Text] [Related]  

  • 11. Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice.
    Fed Regist; 1998 Jun; 63(105):30002-5. PubMed ID: 10180274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA's Kessler stays, NIH's Healy goes.
    Greenberg DS
    Lancet; 1993 Mar; 341(8846):681-2. PubMed ID: 8095583
    [No Abstract]   [Full Text] [Related]  

  • 13. An FDA Commissioner for the 21st Century.
    Chandra A; Sachs RE
    N Engl J Med; 2017 Apr; 376(15):e31. PubMed ID: 28402241
    [No Abstract]   [Full Text] [Related]  

  • 14. John Niederhuber. A physician-scientist takes the helm of NCI.
    Kaiser J
    Science; 2006 Oct; 314(5796):40-2. PubMed ID: 17023626
    [No Abstract]   [Full Text] [Related]  

  • 15. Joint FDA, NCI program aims to streamline cancer drug development.
    FDA Consum; 2003; 37(4):11. PubMed ID: 12971341
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer chief embraces top drugs job.
    Wadman M
    Nature; 2005 Sep; 437(7059):606. PubMed ID: 16193009
    [No Abstract]   [Full Text] [Related]  

  • 17. National Cancer Institute. Klausner quits NCI to head new institute.
    Marshall E
    Science; 2001 Sep; 293(5537):1967. PubMed ID: 11557849
    [No Abstract]   [Full Text] [Related]  

  • 18. Kessler stays, Healy goes.
    Gershon D; Mervis J
    Nature; 1993 Mar; 362(6415):3. PubMed ID: 8446168
    [No Abstract]   [Full Text] [Related]  

  • 19. Budgets up at NIH, NCI, and FDA.
    Cancer Discov; 2014 Mar; 4(3):263. PubMed ID: 24596185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scott Gottlieb and the Credibility of U.S. Therapeutics.
    Carpenter D
    N Engl J Med; 2017 Apr; 376(15):e30. PubMed ID: 28402242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.